CD24 and embryonal carcinoma: CD24 is a membrane protein that has also been proposed as a target for NK-CAR immunotherapy by virtue of its SOX2-mediated transactivation in embryonal carcinoma cells enabling the induction of cell death in CD24-positive cells in vitro [68].